Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Share-based Compensation (2016 - 2026)

United Therapeutics' Share-based Compensation history spans 17 years, with the latest figure at $39.0 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 44.44% to $39.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $147.7 million, a 2.57% increase, with the full-year FY2025 number at $147.7 million, up 2.57% from a year prior.
  • Share-based Compensation hit $39.0 million in Q4 2025 for United Therapeutics, roughly flat from $39.1 million in the prior quarter.
  • Over the last five years, Share-based Compensation for UTHR hit a ceiling of $65.5 million in Q2 2022 and a floor of -$21.1 million in Q1 2022.
  • Historically, Share-based Compensation has averaged $28.8 million across 5 years, with a median of $30.4 million in 2021.
  • Biggest five-year swings in Share-based Compensation: plummeted 152.62% in 2022 and later surged 979.17% in 2023.
  • Tracing UTHR's Share-based Compensation over 5 years: stood at $44.7 million in 2021, then surged by 44.97% to $64.8 million in 2022, then plummeted by 74.38% to $16.6 million in 2023, then surged by 62.65% to $27.0 million in 2024, then skyrocketed by 44.44% to $39.0 million in 2025.
  • Business Quant data shows Share-based Compensation for UTHR at $39.0 million in Q4 2025, $39.1 million in Q3 2025, and $37.8 million in Q2 2025.